Department of Pediatric Surgery, West China Hospital of Sichuan University, Chengdu, 610041, China.
Department of Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, 610041, China.
World J Pediatr. 2022 Dec;18(12):818-824. doi: 10.1007/s12519-022-00603-8. Epub 2022 Sep 13.
The aim of this study was to evaluate the performance of the four scoring tools in predicting mortality in pediatric intensive care units (PICUs) in western China.
This was a multicenter, prospective, cohort study conducted in six PICUs in western China. The performances of the scoring systems were evaluated based on both discrimination and calibration. Discrimination was assessed by calculating the area under the receiver operating characteristic curve (AUC) for each model. Calibration was measured across defined groups based on mortality risk using the Hosmer-Lemeshow goodness-of-fit test.
A total of 2034 patients were included in this study, of whom 127 (6.2%) died. For the entire cohort, AUCs for Pediatric Risk of Mortality Score (PRISM) I, Pediatric Index of Mortality 2 (PIM2), Pediatric Logistic Organ Dysfunction Score-2 (PELOD-2) and PRISM IV were 0.88 [95% confidence interval (CI) 0.85-0.92], 0.84 (95% CI 0.80-0.88), 0.80 (95% CI 0.75-0.85), and 0.91 (95% CI 0.88-0.94), respectively. The Hosmer-Lemeshow goodness-of-fit Chi-square value was 12.71 (P = 0.12) for PRISM I, 4.70 (P = 0.79) for PIM2, 205.98 (P < 0.001) for PELOD-2, and 7.50 (P = 0.48) for PRISM IV [degree of freedom (df) = 8]. The standardized mortality ratios obtained with the PRISM I, PIM2, PELOD-2, and PRISM IV models were 0.87 (95% CI, 0.75-1.01), 0.97 (95% CI, 0.85-1.12), 1.74 (95% CI, 1.58-1.92), and 1.05 (95% CI, 0.92-1.21), respectively.
PRISM IV performed best and can be used as a prediction tool in PICUs in Western China. However, PRISM IV needs to be further validated in NICUs.
本研究旨在评估这四种评分工具在预测中国西部儿科重症监护病房(PICU)患儿死亡率方面的性能。
这是一项在中国西部六家 PICU 进行的多中心、前瞻性队列研究。通过计算每个模型的接收者操作特征曲线(ROC)下面积(AUC)来评估评分系统的性能。基于死亡率风险,使用 Hosmer-Lemeshow 拟合优度检验对校准进行了评估。
本研究共纳入 2034 例患儿,其中 127 例(6.2%)死亡。对于整个队列,儿科死亡风险评分(PRISM)I、儿科死亡率 2 指数(PIM2)、儿科逻辑器官功能障碍评分-2(PELOD-2)和 PRISM IV 的 AUC 分别为 0.88[95%置信区间(CI)0.85-0.92]、0.84(95%CI 0.80-0.88)、0.80(95%CI 0.75-0.85)和 0.91(95%CI 0.88-0.94)。PRISM I 的 Hosmer-Lemeshow 拟合优度卡方值为 12.71(P=0.12),PIM2 的卡方值为 4.70(P=0.79),PELOD-2 的卡方值为 205.98(P<0.001),PRISM IV 的卡方值为 7.50(P=0.48)[自由度(df)=8]。PRISM I、PIM2、PELOD-2 和 PRISM IV 模型获得的标准化死亡率比分别为 0.87(95%CI,0.75-1.01)、0.97(95%CI,0.85-1.12)、1.74(95%CI,1.58-1.92)和 1.05(95%CI,0.92-1.21)。
PRISM IV 表现最佳,可作为中国西部 PICU 的预测工具。然而,PRISM IV 需要在新生儿重症监护病房(NICU)进一步验证。